Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mechanosensitive ion channels (MSCs) are specialized membrane proteins that act as primary mechanotransducers, converting physical forces into electrochemical signals. They respond to stimuli such as membrane stretch, fluid shear stress, and displacement, which trigger the opening of an ion-conducting pore (Coste et al., 2010, Science). These channels, including the Piezo and TRP families, are essential for physiological processes like touch, hearing, baroreception, and blood pressure regulation (Ranade et al., 2015, Neuron). Pathologically, mutations in MSCs are linked to conditions such as hereditary xerocytosis, distal arthrogryposis, and various cardiovascular diseases (Nourse & Pathak, 2017, Circulation Research). They also play a role in cancer progression by sensing changes in the stiffness of the extracellular matrix (Chen et al., 2018, Nature). While historically difficult to target selectively, the discovery of small molecules like Yoda1 and peptide toxins like GsMTx4 has opened avenues for therapeutic intervention (Syeda et al., 2015, eLife). Current drug development efforts aim to modulate these channels to treat chronic pain, hypertension, and skeletal muscle disorders. However, the widespread expression of these channels across different organ systems poses significant challenges for achieving tissue-specific therapeutic effects without adverse safety profiles.
Modulation of ion channel gating in response to mechanical force, either by directly opening the pore (agonism) or inhibiting the mechanical response (antagonism/blockade).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanosensitive ion channel (MSC) (MSC).